SPATA: Strong Pseudonym based AuthenTicAtion in Intelligent Transport System

Intelligent Transport System (ITS) is generally deployed to improve road safety, comfort, security, and traffic efficiency. A robust mechanism of authentication and secure communication is required to protect privacy and conditional resolution of pseudonyms to revoke malicious vehicles. In a typical ITS framework, a station can be a vehicle, Road Side Unit (RSU), or a server that can participate in communication. During authentication, the real identity of an Intelligent Transport System-Station (ITSS), referred to as a vehiclečň should not be revealed in order to preserve its privacy. In this paper, we propose a Strong Pseudonym based AutenTicAtion (SPATA) framework for preserving the real identity of vehicles. The distributed architecture of SPATA allows vehicles to generate pseudonyms in a very private and secure way. In the absence of a distributed architecture, the privacy cannot be preserved by storing information regarding vehicles in a single location. Therefore, the concept of linkability of certificates based on single authority is eliminated. This is done by keeping the real identity to pseudonym mappings distributed. Furthermore, the size of the Certificate Revocation List (CRL) is kept small, as only the most recent revoked communication pseudonyms are kept in the CRL. The privacy of the vehicle is preserved during the revocation and resolution phase through the distributed mechanism. Empirical results show that SPATA is a lightweight framework with low computational overhead, average latency, overhead ratio, and stable delivery ratio, in both sparse and dense network scenarios

Issues, Challenges, and Research Opportunities in Intelligent Transport System for Security and Privacy

Intelligent transport system (ITS), owing to their potential to enhance road safety and improve traffic management, have attracted attention from automotive industries and academia in recent years. The underlying technology—i.e., vehicular ad-hoc networks (VANETs)—provide a means for vehicles to intelligently exchange messages regarding road and traffic conditions to enhance safety. The open nature of ITS as wireless communication technology leads to many security and privacy challenges. These challenges pertain to confidentiality, authentication, integrity, non-repudiation, location privacy, identity privacy, anonymity, certificate revocation, and certificate resolution. This article aims to propose a novel taxonomy of security and privacy issues and solutions in ITS. Furthermore, categorization of security and privacy schemes in ITS and their limitations are discussed with various parameters—scalability, privacy, computational cost, communication overhead, latency—and various types of security attacks has been analyzed. This article leverages new researchers for challenges and opportunities related to security and privacy in ITS

The prevalence of neuromyelitis optica in South East Wales

Background and purpose: Neuromyeltis optica (NMO) is a neuroinflammatory disorder considered rare in Caucasian populations. However, accurate population-based epidemiological data for NMO and NMO spectrum disorder (NMO-SD) from Western populations employing validated diagnostic criteria remain limited. We sought therefore to estimate the prevalence and clinical features of NMO in a north European Caucasian population in South East Wales. Methods: Patients were identified by a comprehensive, multistage ascertainment strategy employing a regional neuroinflammatory disease register, hospital diagnostic databases personal physician referrals and regional requests for anti-aquaporin-4 antibodies (anti-AQP4). Results: Fourteen Caucasian patients (11 patients with NMO and three with NMO-SD) were identified in a population of 712 572 (19.6/million; 95% CIs: 12.2–29.7). There was an excess of females (female:male 12:2), 11/14 were anti-AQP4 positive and 5/14 had disease onset under the age of 20 years. Conclusion: This study suggests that NMO and related spectrum disorders are at least as frequent in Northern European populations as in non-Caucasian populations and that the demographic profile of prevalent patients differs from clinic-based cohorts

Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS

Background and Purpose: Although most strokes present with mild symptoms, these have been poorly represented in clinical trials. The objective of this study is to describe multidimensional outcomes, identify predictors of worse outcomes, and explore the effect of thrombolysis in this population. Methods: This prospective observational study included patients with ischemic stroke or transient ischemic attack, a baseline National Institutes of Health Stroke Scale (NIHSS) score 0 to 5, presenting within 4.5 hours from symptom onset. The primary outcome was a 90-day modified Rankin Scale score of 0 to 1; secondary outcomes included good outcomes in the Barthel Index, Stroke Impact Scale-16, and European Quality of Life. Multivariable models were created to determine predictors of outcomes and the effect of alteplase. Results: A total of 1765 participants were included from 100 Get With The Guidelines-Stroke participating hospitals (age, 65±14; 42% women; final diagnosis of ischemic stroke, 90%; transient ischemic attack, 10%; 57% received alteplase). At 90 days, 37% were disabled and 25% not independent. Worse outcomes were noted for older individuals, women, non-Hispanic Blacks and Hispanics, Medicaid recipients, smokers, those with diabetes, atrial fibrillation, prior stroke, higher baseline NIHSS, visual field defects, and extremity weakness. Similar outcomes were noted for the alteplase-treated and untreated groups. Alteplase-treated patients were younger (64±13 versus 67±1.4) with higher NIHSS (2.9±1.4 versus 1.7±1.4). After adjusting for age, sex, race/ethnicity, and baseline NIHSS, we did not identify an effect of alteplase on the primary outcome but did find an association with Stroke Impact Scale-16 in the restricted sample of baseline NIHSS score 3–5. Few symptomatic intracerebral hemorrhages were recorded (<1%). Conclusions: A large proportion of stroke patients presenting with low NIHSS have a disabled outcome. Baseline predictors of worse outcomes are described. An effect of alteplase on outcomes was not identified in the overall cohort, but a suggestion of efficacy was noted in the NIHSS 3–5 subgroup. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02072681